Literature DB >> 15686626

Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress.

Jean Yj Wang1.   

Abstract

Genotoxic agents or inflammatory cytokines activate cellular stress responses and trigger programmed cell death. We have identified a signal transduction module, including three nuclear proteins that participate in the regulation of cell death induced by chemotherapeutic agents and tumor necrosis factor (TNF). In this nuclear signaling module, retinoblastoma protein (Rb) functions as an inhibitor of apoptotic signal transduction. Inactivation of Rb by phosphorylation or caspase-dependent cleavage/degradation is required for cell death to occur. Rb inhibits the Abl tyrosine kinase. Thus, Rb inactivation is a pre-requisite for Abl activation by DNA damage or TNF. Activation of nuclear Abl and its downstream effector p73 induces mitochondriadependent cell death. The involvement of these nuclear signal transducers in TNF induced apoptosis, which does not require new gene expression, indicates that nuclear events other than transcription can contribute to extrinsic apoptotic signal transduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686626     DOI: 10.1038/sj.cr.7290263

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  21 in total

1.  Plasmonic imaging of human oral cancer cell communities during programmed cell death by nuclear-targeting silver nanoparticles.

Authors:  Lauren A Austin; Bin Kang; Chun-Wan Yen; Mostafa A El-Sayed
Journal:  J Am Chem Soc       Date:  2011-10-18       Impact factor: 15.419

2.  c-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization.

Authors:  Maria Giovanna di Bari; Laura Ciuffini; Michele Mingardi; Roberto Testi; Silvia Soddu; Daniela Barilà
Journal:  EMBO Rep       Date:  2006-04-28       Impact factor: 8.807

3.  CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

Authors:  Jingying Xu; Jemima Escamilla; Stephen Mok; John David; Saul Priceman; Brian West; Gideon Bollag; William McBride; Lily Wu
Journal:  Cancer Res       Date:  2013-02-15       Impact factor: 12.701

4.  Detection of early Abl kinase activation after ionizing radiation by using a peptide biosensor.

Authors:  Jiabin Tang; Jean Y Wang; Laurie L Parker
Journal:  Chembiochem       Date:  2012-02-14       Impact factor: 3.164

5.  Selective targeting of c-Abl via a cryptic mitochondrial targeting signal activated by cellular redox status in leukemic and breast cancer cells.

Authors:  Jonathan E Constance; Samuel D Despres; Akemi Nishida; Carol S Lim
Journal:  Pharm Res       Date:  2012-05-02       Impact factor: 4.200

6.  Tumor promotion by caspase-resistant retinoblastoma protein.

Authors:  Helena L Borges; Jeff Bird; Katherine Wasson; Robert D Cardiff; Nissi Varki; Lars Eckmann; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-14       Impact factor: 11.205

7.  Autophagy and Apoptosis Specific Knowledgebases-guided Systems Pharmacology Drug Research.

Authors:  Peihao Fan; Nanyi Wang; Lirong Wang
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

8.  Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms.

Authors:  Xiaoqing Cao; Keith Q Tanis; Anthony J Koleske; John Colicelli
Journal:  J Biol Chem       Date:  2008-09-16       Impact factor: 5.157

9.  SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival.

Authors:  Laura Tonnetti; Sarah Netzel-Arnett; Grant A Darnell; Tamara Hayes; Marguerite S Buzza; Ian E Anglin; Andreas Suhrbier; Toni M Antalis
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

Review 10.  Targeting malignant mitochondria with therapeutic peptides.

Authors:  Jonathan E Constance; Carol S Lim
Journal:  Ther Deliv       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.